Impact of Guideline-Directed Management Strategies for Low-Density Lipoprotein Cholesterol Control in Patients Who Underwent Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Impact of Guideline-Directed Management Strategies for Low-Density Lipoprotein Cholesterol Control in Patients Who Underwent Percutaneous Coronary Intervention

Published:2024-02 Issue: Volume:213 Page:20-27
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Park Jong-Il^ORCID,Song Ji-Hyun,Bae Yeong-Hui,Cho Yu-Hyun,Son Byeong-Ju,Kim Hong-Ju,Choi Gang-Un,Nam Jong-Ho,Lee Chan-Hee,Son Jang-Won,Park Jong-Seon,Kim Ung

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2020

2. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines;Grundy;Circulation,2019

3. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial;Pedersen;JAMA,2005

4. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N Engl J Med,2004

5. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Density Lipoprotein Cholesterol-Lowering Therapy for Atherosclerotic Cardiovascular Disease in the Future;The American Journal of Cardiology;2024-01